SICKLE CELL THALASSEMIA IN AN ADULT FROM CENTRAL INDIA SHOWING MASSIVE SPLENIC INFARCTION AND GAMNA-GANDY BODIES IN SPLENIC PARENCHYMA WITH CONCOMITANT PLASMODIUM FALCIPARUM INFECTION
(case report)
DOI:
https://doi.org/10.11603/ijmmr.2413-6077.2022.2.13152Keywords:
sickle-cell anemia, beta-thalassemia, malaria, plasmodium falciparum, Gamna-Gandy bodiesAbstract
Background. Sickle cell thalassemia is a heterozygous state of HbS/β+ or HbS/β0 manifested clinically either as an asymptomatic carrier or have features akin to sickle cell anemia.
Objective. The aim of the study is to review the literature and discuss the varied clinical manifestations and diagnosis of a case report of haemoglobinopathy in an adult from Central India.
Methods. A case of haemoglobinopathy from central part of India is being investigated.
Results. A case of haemoglobinopathy in an adult presenting to a tertiary hospital with chronic back ache was reported. The patient was found to have massive splenomegaly with evidence of splenic infarction. Gross examination of spleen revealed multiple soft yellowish pasty areas, which on microscopic examination showed significant necrosis with presence of great amount pale amorphous yellow substance, Gamna-Gandy bodies (GGBs) and massive foreign body cell reaction in splenic parenchyma. Post-splenectomy peripheral blood smear (PBS) showed thrombocytosis and plasmodium falciparum gametocytes. The Hb electrophoresis revealed both elevation of Hb S (49.7%), Hb F (46.7%); Hb A2 (3.0%) and (Hb A 0.7%) consistent with as Sickle Cell Thalassemia Hb S/β+ Thalassemia.
Conclusion. Sickle cell thalassemia with long standing huge splenomegaly, splenic infarction with GGBs deposition and concomitant falciparum malaria in clinically stable patient is rare indeed.
References
Silvestroni E, Bianco I. Microdrepanocito-anemia in un soggetto di razza Bianca. Boll A Accad Med Roma 1944; 70:347.
Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, Sharma SK, Chaudhari U, Ghosh M, Das S, Britt RP, Singh S, Ross C, Jagannathan L, Kaul R, Shukla DK, Muthuswamy V. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet.2013; 4(1):33-42.
https://doi.org/10.1007/s12687-012-0114-0
Serjeant GR, Ashcroft MT, Serjeant BE, Milner PF. The clinical features of sickle-cell- thalassaemia in Jamaica. Br J Haematol. 1973; 24(1): 19-30.
https://doi.org/10.1111/j.1365-2141.1973.tb05723.x
Kinney TR, Ware RE. Compound heterozygous states. Sickle cell disease: basic principles and clinical practice. 1994; 29:437-52.
Steinberg MH. Compound heterozygous and other sickle hemoglobinopathies. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. 2001:786-810.
Schmugge M, Waye JS, Basran RK, Zurbriggen K, Frischknecht H. THE Hb S/β+-Thalassemia Phenotype Demonstrates that the IVS-I (− 2)(A>C) Mutation is a Mild β-Thalassemia Allele. Hemoglobin. 2008; 32(3):303-7.
https://doi.org/10.1080/03630260802004459
Divoky V, Baysal E, Schiliro G, Dibenedetto SP, Huisman TH. A mild type of Hb S-β+-thalassemia
[-92 (C→T)] in a sicilian family. American journal of hematology. 1993; 42(2):225-6.
https://doi.org/10.1002/ajh.2830420216
Leffler EM, Band G, Busby GB, Kivinen K, Le QS, Clarke GM, Bojang KA, Conway DJ, Jallow M, Sisay-Joof F, Bougouma EC. Resistance to malaria through structural variation of red blood cell invasion receptors. Science. 2017; 356(6343).
https://doi.org/10.1126/science.aam6393
Luzzatto L. Sickle cell anaemia and malaria. Mediterranean journal of hematology and infectious diseases. 2012; 4(1).
https://doi.org/10.4084/mjhid.2012.065
McAuley CF, Webb C, Makani J, Macharia A, Uyoga S, Opi DH, Ndila C, Ngatia A, Scott JA, Marsh K, Williams TN. High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood, The Journal of the American Society of Hematology. 2010; 116(10):1663-8.
https://doi.org/10.1182/blood-2010-01-265249
Makani J, Komba AN, Cox SE, Oruo J, Mwamtemi K, Kitundu J, Magesa P, Rwezaula S, Meda E, Mgaya J, Pallangyo K. Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood, The Journal of the American Society of Hematology. 2010; 115(2):215-20.
https://doi.org/10.1182/blood-2009-07-233528
Tubman VN, Makani J. Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions. British journal of haematology. 2017; 177(6):938-46.
https://doi.org/10.1111/bjh.14592
Brousse V, Buffet P, Rees D. The spleen and sickle cell disease: the sick (led) spleen. British journal of haematology. 2014; 166(2):165-76.
https://doi.org/10.1111/bjh.12950
Chotivanich K, Udomsangpetch R, McGready R, Proux S, Newton P, Pukrittayakamee S, Looareesuwan S, White NJ. Central role of the spleen in malaria parasite clearance. Journal of Infectious Diseases. 2002; 185(10):1538-41.
https://doi.org/10.1086/340213
Demar M, Legrand E, Hommel D, Esterre P, Carme B. Plasmodium falciparum malaria in splenectomized patients: two case reports in French Guiana and a literature review. The American journal of tropical medicine and hygiene. 2004; 71(3):290-3.
https://doi.org/10.4269/ajtmh.2004.71.290
Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clinical microbiology reviews. 2009; 22(1):13-36.
https://doi.org/10.1128/CMR.00025-08
Färnert A, Wyss K, Dashti S, Naucler P. Duration of residency in a non-endemic area and risk of severe malaria in African immigrants. Clinical Microbiology and Infection. 2015; 21(5):494-501.
https://doi.org/10.1016/j.cmi.2014.12.011
Olaosebikan R, Ernest K, Bojang K, Mokuolu O, Rehman AM, Affara M, Nwakanma D, Kiechel JR, Ogunkunle T, Olagunju T, Murtala R. A randomized trial to compare the safety, tolerability, and effectiveness of 3 antimalarial regimens for the prevention of malaria in Nigerian patients with sickle cell disease. The Journal of infectious diseases. 2015; 212(4):617-25.
https://doi.org/10.1093/infdis/jiv093
Kleinschmidt-DeMasters BK. Gamna-Gandy bodies in surgical neuropathology specimens: observations and a historical note. Journal of Neuropathology & Experimental Neurology. 2004; 63(2):106-12.
https://doi.org/10.1093/jnen/63.2.106
Piccin A, Rizkalla H, Smith O, McMahon C, Furlan C, Murphy C, Negri G, Mc Dermott M. Composition and significance of splenic Gamna-Gandy bodies in sickle cell anemia. Human pathology. 2012; 43(7):1028-36.
https://doi.org/10.1016/j.humpath.2011.08.011
Tedeschi LG. The Gamna nodule. Hum Pathol. 1971;2(1):182-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 International Journal of Medicine and Medical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
